Short Interest in Alpha Tau Medical Ltd. (NASDAQ:DRTS) Increases By 7.1%

Alpha Tau Medical Ltd. (NASDAQ:DRTS) was the recipient of a large increase in short interest in January. As of January 15th, there was short interest totalling 72,600 shares, an increase of 7.1% from the December 31st total of 67,800 shares. Based on an average trading volume of 45,600 shares, the days-to-cover ratio is presently 1.6 days. Approximately 0.1% of the company’s stock are short sold.

Alpha Tau Medical Stock Performance

NASDAQ:DRTS traded down $0.13 during trading on Tuesday, reaching $3.40. The company’s stock had a trading volume of 22,231 shares, compared to its average volume of 149,735. The firm has a 50 day moving average of $3.35 and a 200-day moving average of $2.63. The firm has a market cap of $237.73 million, a price-to-earnings ratio of -7.92 and a beta of 0.83. Alpha Tau Medical has a 12 month low of $1.75 and a 12 month high of $4.39.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright reiterated a “buy” rating and issued a $9.00 price objective on shares of Alpha Tau Medical in a research note on Friday, November 22nd.

About Alpha Tau Medical

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, prostate, and breast cancers; and preclinical studies for brain, hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others.